申请人:Epix Medical, Inc., a Delaware corporation
公开号:US20040005274A1
公开(公告)日:2004-01-08
The present invention relates to contrast agents for diagnostic imaging. In particular, this invention relates to novel multimeric compounds which exhibit improved relaxivity properties upon binding to endogenous proteins or other physiologically relevant sites. The compounds consist of:
a) two or more Image Enhancing Moieties (IEMs) (or signal-generating moiety) comprising multiple subunits;
b) two or more Target Binding Moieties (TBMs), providing for in vivo localization and multimer rigidification; and
c) a scaffold framework for attachment of the above moieties.
d) optional linkers for attachment of the IEMs to scaffold.
This invention also relates to pharmaceutical compositions comprising these compounds and to methods of using the compounds and compositions for contrast enhancement of diagnostic imaging.
本发明涉及用于诊断成像的对比剂。具体而言,本发明涉及新型多聚合物化合物,当与内源蛋白质或其他生理相关部位结合时,表现出改进的弛豫性能。该化合物包括:a) 两个或更多图像增强基团(IEMs)(或信号产生基团),包括多个亚基;b) 两个或更多靶向结合基团(TBMs),提供体内定位和多聚刚化;和c) 用于连接上述基团的支架框架。d) 可选的连接剂,用于将IEMs连接到支架。本发明还涉及包含这些化合物的药物组合物,以及使用这些化合物和组合物增强诊断成像对比度的方法。